MeiraGTx (NASDAQ:MGTX) Trading Up 7.6% – What’s Next?

by · The Cerbat Gem

MeiraGTx Holdings PLC (NASDAQ:MGTXGet Free Report) was up 7.6% during trading on Friday . The stock traded as high as $9.32 and last traded at $9.3850. Approximately 203,987 shares were traded during trading, a decline of 60% from the average daily volume of 506,077 shares. The stock had previously closed at $8.72.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of MeiraGTx in a research note on Wednesday, October 8th. Chardan Capital reissued a “buy” rating and set a $35.00 price objective on shares of MeiraGTx in a report on Tuesday, November 11th. Royal Bank Of Canada upped their price target on MeiraGTx from $12.00 to $16.00 and gave the stock an “outperform” rating in a report on Friday, November 14th. HC Wainwright started coverage on MeiraGTx in a research note on Monday, November 24th. They set a “buy” rating and a $20.00 price objective on the stock. Finally, Wall Street Zen downgraded shares of MeiraGTx from a “hold” rating to a “sell” rating in a report on Saturday, November 15th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, MeiraGTx has an average rating of “Moderate Buy” and an average target price of $26.00.

Read Our Latest Analysis on MeiraGTx

MeiraGTx Price Performance

The firm has a market cap of $741.23 million, a PE ratio of -4.36 and a beta of 1.38. The company has a debt-to-equity ratio of 26.29, a current ratio of 0.22 and a quick ratio of 0.22. The business’s fifty day moving average is $8.34 and its 200-day moving average is $7.73.

MeiraGTx (NASDAQ:MGTXGet Free Report) last announced its quarterly earnings data on Thursday, November 13th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.50) by ($0.12). MeiraGTx had a negative return on equity of 1,065.47% and a negative net margin of 615.27%.The firm had revenue of $0.41 million during the quarter, compared to analysts’ expectations of $7.71 million. On average, research analysts predict that MeiraGTx Holdings PLC will post -1.48 earnings per share for the current fiscal year.

Insider Transactions at MeiraGTx

In other MeiraGTx news, CFO Richard Giroux sold 24,000 shares of the company’s stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of $8.87, for a total value of $212,880.00. Following the transaction, the chief financial officer directly owned 829,494 shares in the company, valued at $7,357,611.78. This represents a 2.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Alexandria Forbes sold 47,500 shares of MeiraGTx stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $8.39, for a total value of $398,525.00. Following the sale, the chief executive officer owned 1,313,983 shares of the company’s stock, valued at approximately $11,024,317.37. This trade represents a 3.49% decrease in their position. The SEC filing for this sale provides additional information. 7.50% of the stock is owned by corporate insiders.

Institutional Trading of MeiraGTx

Hedge funds have recently made changes to their positions in the stock. Kennedy Capital Management LLC lifted its position in MeiraGTx by 3.8% in the 2nd quarter. Kennedy Capital Management LLC now owns 35,189 shares of the company’s stock worth $229,000 after buying an additional 1,287 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of MeiraGTx by 43.8% in the 2nd quarter. BNP Paribas Financial Markets now owns 4,810 shares of the company’s stock worth $31,000 after acquiring an additional 1,466 shares during the last quarter. Rhumbline Advisers boosted its stake in shares of MeiraGTx by 6.1% in the 1st quarter. Rhumbline Advisers now owns 58,227 shares of the company’s stock valued at $395,000 after purchasing an additional 3,336 shares in the last quarter. Russell Investments Group Ltd. raised its position in MeiraGTx by 4.3% in the 3rd quarter. Russell Investments Group Ltd. now owns 82,844 shares of the company’s stock worth $682,000 after purchasing an additional 3,452 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in MeiraGTx by 3.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 116,027 shares of the company’s stock worth $787,000 after purchasing an additional 4,006 shares during the last quarter. 67.48% of the stock is owned by institutional investors.

About MeiraGTx

(Get Free Report)

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.

Featured Articles